 |
 |
HK J Paediatr (New Series)
Vol 26. No. 3,
2021
|
|
HK J Paediatr (New Series) 2021;26:175-179
Contemporary Practice in Paediatrics
Joint Position Statement on BioNTech Vaccination in Adolescents with Allergic Diseases
TF Leung, WY Tse, WH Chan; On behalf of Hong Kong College of Paediatricians and Hong Kong Society for Paediatric Immunology Allergy and Infectious Diseases Vice President and Chairman of Education Committee, Hong Kong College of Paediatricians; and Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China TF Leung (梁廷勳) MD, FHKAM(Paed) President, Hong Kong College of Paediatricians, Hong Kong SAR, China WY Tse (謝詠儀) FHKAM(Paed) President, Hong Kong Society for Paediatric Immunology Allergy and Infectious Diseases; and Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong SAR, China WH Chan (陳偉雄) FHKAM(Paed) Correspondence to: Prof TF Leung Email: enquiry@paediatrician.org.hk Received June 15, 2021
Abstract This Statement was prepared to encourage Hong Kong adolescents aged 12-17 years old to receive BioNTech vaccine and recommend when to refer them for vaccine allergy evaluation. Importantly, the personal and societal benefits of BioNTech vaccination outweigh the risk of non-severe adverse vaccine reactions. BioNTech is currently contraindicated only in individuals with history of anaphylaxis to this vaccine or its components (e.g., polyethylene glycol [PEG]) by appropriate allergy testing. Subjects with history of immediate and severe allergic reactions to PEG-containing drugs or vaccines or immediate allergic reaction to the first dose of BioNTech warrant paediatric allergy referral to evaluate their fitness to receive this vaccine. Allergy to unrelated drugs, food, insect venoms as well as asthma, allergic rhinitis and eczema are not contraindications for BioNTech. Patients with a history of severe allergic reactions after foods, unrelated drugs or vaccines can receive BioNTech with a longer observation of 30 minutes post-vaccination. Keyword : Adolescent; Allergy; Contraindication; COVID-19; mRNA vaccine
|
|
 |